1. Home
  2. AREC vs HELP Comparison

AREC vs HELP Comparison

Compare AREC & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Resources Corporation

AREC

American Resources Corporation

HOLD

Current Price

$3.12

Market Cap

317.5M

Sector

Energy

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$4.74

Market Cap

281.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AREC
HELP
Founded
2013
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.5M
281.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AREC
HELP
Price
$3.12
$4.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$6.50
$95.00
AVG Volume (30 Days)
2.1M
1.1M
Earning Date
03-27-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$42,083.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$4.52
52 Week High
$7.11
$8.55

Technical Indicators

Market Signals
Indicator
AREC
HELP
Relative Strength Index (RSI) 48.70 35.51
Support Level $2.96 N/A
Resistance Level $3.30 $7.28
Average True Range (ATR) 0.24 0.57
MACD -0.01 -0.21
Stochastic Oscillator 37.31 5.71

Price Performance

Historical Comparison
AREC
HELP

About AREC American Resources Corporation

American Resources Corp constructs and/or purchases and manages a chain of combined gasoline, diesel and natural gas (NG) fueling and service stations; construct conversion factories to convert NG to liquefied natural gas (LNG) and compressed natural gas (CNG); and construct conversion factories to retrofit vehicles currently using gasoline or diesel fuel to also run on NG in the United States and also to build a convenience store to serve its customers in each of its locations. Its segments are AIC focused on the extraction, processing, transportation, and distribution of coal for a variety of industries, with a focus on metallurgical quality coal to the steel industry; RLMT; and EMC.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.

Share on Social Networks: